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Piezophotonic materialsPhotoacoustic (PA) waves generated by short laser pulses absorbed by piezophotonic materials are shown to
permeabilize the stratum corneum to large molecules and proteins. Two minutes of such PA waves at a laser
pulse frequency of 20 Hz increase the transepidermal water loss (TEWL) of healthy human skin by a factor of
2.5, and the skin relaxes to normal two minutes later. The intraepidermal delivery of Green Fluorescence Pro-
tein (GFP) in minipigs with this method does not lead to observable adverse effects. The distinctive features
of the piezophotonic materials are the high light-to-pressure conversion efﬁciency and the generation of PA
waves with the duration of the laser pulses. Such features combine to yield broadband pressure waves with
steep pressure gradients that are capable of permeabilizing the stratum corneum.
© 2013 Elsevier B.V. Open access under CC BY-NC-ND license.1. Introduction
The remarkable protection against chemicals and pathogens pro-
vided by the skin also limits transdermal delivery to a very small set
of the medicines available today [1]. The physicochemical properties
of good skin penetrants are even more restrictive [2] than those of
drugs intended for oral delivery [3]. The permeability of the skin
can be increased with topical formulations, or transdermal patches,
containing chemical penetration enhancers, but there are fundamen-
tal constraints in their design associated with their skin irritation po-
tential [4]. These difﬁculties motivated the development of a wide
range of physical methods to actively deliver drugs through the
skin. The use of electrical (iontophoresis, electroporation), mechani-
cal (microneedles, ballistic injectors), thermal (thermal ablation) or
pressure (ultrasound, stress transients) methods opened new per-
spectives for the transdermal delivery of drugs [5–9]. However, the
need for safe, painless, efﬁcient and affordable transdermal delivery
of drugs remains unfulﬁlled and the most relevant alternative to the
oral delivery of drugs is still the use of hypodermic needles, regardless
of pain, contaminations and waste. This work presents a physical
method based on ultrahigh-frequency ultrasound waves with steep
pressure gradients that transiently perturb the outer-skin barrier
and facilitate drug delivery.
The grand challenge of transdermal drug delivery is not just to bypass
the efﬁcient protection of our skin against the ingressionof chemicals and
pathogens. Transdermal delivery aims at painless and fast transport of
drugs through the skin without damaging it, such that the skin recovers+351 239 827703.
NC-ND license.its protective function and original appearance shortly after the treat-
ment. Themain contributor to the impermeability of the skin is its outer-
most layer, called stratum corneum (SC), although it is only 10 to 20 μm
thick. It is made by a dozen layers of hardly packed nonliving corneocyte
cells embedded in a mixture of lipids with high spatial organization [10].
Most molecules penetrate the skin by diffusion through the intercellular
lipids, a narrow and tortuous path around the corneocytes that is highly
constrained by structural and solubility requirements. Molecules heavier
than 400–500 Da are unable to ﬁnd sufﬁciently wide defects in the
intercellular lipid matrix to start diffusing through the lipidic parts of
the SC barrier and remain essentially conﬁned to the skin surface [6].
Hydrophilic transepidermal pathways can be found between corneocyte
clusters but impose even more strict size restrictions [6].
The steady-state water vapor ﬂux crossing the skin to the external
environment, or transepidermal water loss (TEWL), reﬂects the barrier
function of the skin. The value of TEWL changes with the anatomical
site, environmental conditions and, to some extent, with the equipment
employed in themeasurement [11–15]. TEWLmeasurements often em-
ploy the ventral forearms of healthy volunteers, and values between 5
and 14 g/(m2 h) were reported. This should not be interpreted as lack
of precision of the measurements, but rather as warning against com-
parison between absolutemeasurements performed in different labora-
tories. The precision of the measurements in a given setting is usually
high, e.g. 6.4 g/(m2 h) with a standard deviation of 2.08 g/(m2 h) [11]
or 14.5±3.2 g/(m2 h) [13], provided that the same equipment is used
with the same protocol and under the same environmental conditions.
Although the correlation between the TEWL and the percutaneous ab-
sorption rates of drugs may not be entirely general, it is nevertheless
widely recognized that the TEWL is a measure of the skin barrier func-
tion and permeability [14,16–19].
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Fig. 1. Rationalization of the increased skin permeability following the application of
photoacoustic waves with frequencies above 100 MHz. a, Unperturbed stratum
corneum, shown as 14 layers of tightly packed corneocytes with hydrophilic domains
(blue) separated by intercellular lipid lamellae (green), where the diameter of the
corneocytes (40 μm) is not represented to the scale. b, Compressive front and rarefac-
tion tail of a photoacoustic wave with a steep pressure gradient traversing the stratum
corneum and producing very fast pressure changes. c, Perturbed stratum corneumwith
expansion of the lacunar spaces where the organization of the lipid matrix is changed
and takes some time to relax to the original structure, which facilitates the diffusion of
drugs through the expanded spaces, which correspond to pores in a 3D view.
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the extracellular domains of the SC, and enhanced transdermal delivery
of large drugswas observedwhen high-frequency (16 MHz) ultrasound
[20], low-frequency (20–25 kHz) sonophoresis [21,22] or just the use of
surfactants [23] expanded lacunar domains. Shock waves are also be-
lieved to use this mechanism to increase the permeability of the skin
[24,25]. This work shows how to permeabilize the stratum corneum
using photoacoustic (PA) waves generated by the thermoelastic expan-
sion of materials characterized by efﬁcient and ultrafast conversion of
light into pressure at optical power densities (or ﬂuence rates) of porta-
ble pulsed lasers (ILb10 MW/cm2 per pulse, e.g. a 100 mJ/cm2 laser
pulse with a duration τL=10 ns). Experiments ﬁrst performed with
minipigs, in view of the similarity between their skin and human skin,
and then with healthy volunteers, show that the SC becomes very per-
meable to largemolecules andproteins for a fewminutes after the appli-
cation of PA waves and then totally recovers its protective function. The
PA waves employed in this work do not have the high intensities and
low frequencies required to produce cavitation. On the other hand,
they have very sort durations, as short as the nanosecond laser pulses
employed to generate them, and even with moderate pressure ampli-
tudes, they achieve very accentuated pressure gradients. We show
that the PAwaves generatedwith ourmethod produce a pressure gradi-
ent of more than one bar across a single cell, as illustrated in Fig. 1, and
this is the origin of the perturbation of the SC structure.
2. Theory
Thermoelastic expansion is usually considered an inefﬁcient
method to convert a pulse of light into a pressure wave because the ob-
served optical-to-acoustic energy conversion efﬁciencies are typically
ηPAb10−5 [26–28]. However, this is much lower the theoretical efﬁ-
ciency of photoacoustic conversion. The maximum pressure amplitude
generated by thermoelastic expansion after absorption of a laser pulse
with the optical power density IL is given by [29]
pmax ¼ ILγ=cs ð1Þ
where the Grüneisen coefﬁcient γ characterizes the thermoelastic be-
havior of materials and cs is the longitudinal speed of sound. Consider-
ing that for pbbρcs2, where ρ is the density, the average sound power
density (i.e., the rate of energy ﬂow through a unit area perpendicular
to the direction of propagation) is [30]
Is ¼ p2= ρcsð Þ ð2Þ
and we anticipate that the efﬁciency of light-to-pressure transduction
increases with the optical power density
ηPA ¼ Is=IL ¼ ILγ2= ρcs3
 
ð3Þ
This relation holds true below the ablation threshold of thematerial.
For polystyrene (γ =0.70 [31], cs=2400 m/s and ρ=1050 kg/m3
[32]) doped with a dye absorbing all the incident light, the maximum
PA conversion efﬁciency is limited by its ablation threshold at IL=
15 MW/cm2 [33], and is ηPA=0.005. Higher conversion efﬁciencies
can be expected for materials with high Grüneisen coefﬁcients and
higher ablation thresholds.
These theoretical estimates reveal that PA conversion is not intrin-
sically inefﬁcient. The conversion efﬁciency can be experimentally
improved with laser pulse shaping and materials that meet the
following properties:
(i) Thermal conﬁnement – the laser pulse duration is shorter than
the thermal diffusion time, τLbτd, where τd=(ρ Cp)/(κt μa2). Under
this condition, the short duration of the laser pulse restricts the ener-
gy deposition to the absorbing volume [34].(ii) Optical conﬁnement – the strong light absorption by the mate-
rial makes the acoustic relaxation time τs shorter than the laser pulse,
τsbτL, where τs=1/(μacs). Under this condition, the spectral band of
the laser pulse will determine the spectral band of the PA wave
[35], and short laser pulses give ultrahigh frequency waves.
In the expressions above, Cp is the speciﬁc heat capacity, μa the lin-
ear absorption coefﬁcient and κt the thermal conductivity of the ab-
sorbing material. It is implicit in the optical conﬁnement limit that
the electronic states formed by the absorption of light decay back to
their ground state in a time shorter than the duration of the laser
pulse, as in the compounds used as references for photoacoustic
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photoacoustic spectral conﬁnement.
The efﬁciency of PA conversion can also be increasedwith appropri-
ate design of the conversion device. First, the generation of pressure
waves by thermoelastic expansion increases when the absorbingmedi-
um is conﬁned by rigid boundaries [38,39]. Second, the peak pressures
obtained by thermoelastic expansion scale with the reciprocal of the
thickness (h) of absorbing material for the same amount of energy
absorbed [40],
Δp ¼ ΔHthγ=h ð4Þ
where ΔHth is the thermal energy released per unit area, because the
thermal energy is released in a smaller volume. However, aword of cau-
tion is in order. The limits of photoacoustic spectral conﬁnement re-
quire, for example, that an 8 ns laser pulse is “totally” absorbed by a
material with μa>1100 cm−1 at the laser wavelength, which may be
difﬁcult to fabricate.
Biagi et al. reported heavily absorbing ﬁlms designed tomaximize the
value of ηPA and obtained a conversion efﬁciency ηPA≈10−6 [27]. This
disappointing efﬁciency can be assigned to the low power densities
employed: IL=0.4 MW/cm2 produced a PA wave with pmax=0.1 bar.
Guo et al. developed photonic crystal-metallic structures with a layer of
an elastomer and operated in a total-internal-reﬂection geometry to ob-
tain pmax=2.4 bar with IL=1.8 MW/cm2 [41], i.e. ηPA≈3×10−6. This is
one of the highest conversion efﬁciencies reported in the literature, al-
though it did not make use of conﬁnement by rigid interfaces. We
designed light-to-pressure transducer materials guided by the relations
described above. These materials are very thin (thicknessb100 μm) and
strongly absorbing (μa>100 cm−1) ﬁlms that are incorporating dyes
with ultrafast radiationless decays (transient lifetimes b1 ns). We name
such materials “piezophotonic”. A polystyrene-based piezophotonic
material with μa=500 cm−1 is in the limit of generating a PA wave
with the time dependence of a laser pulse with τL=8 ns.
3. Materials and methods
3.1. Piezophotonic materials and pressure measurements
Light-to-pressure transducer ﬁlms were casted from a mixture of
polystyrene and either MnIII 5,10,15,20-tetraphenylporphyrinate
(Mn-TPP) or MnIII 5,10,15,20-tetraundecylporphyrinate (Mn-TUP)
using an Elcometer 3505 cube ﬁlm applicator. Polystyrene and toluene
were mixed and stirred until the entire polymer was dissolved. The dye
was then added to polystyrene/toluene and all the mixture was stirred
until the dye was completely dissolved. Air bubbles resulting from stir-
ring were eliminated placing the polystyrene/toluene/dye in an ultra-
sonic bath for some minutes. Finally, the mixture was poured into the
mold and spread on a clean glass sheet. The ﬁlms deposited by casting
were dried at room temperature and then removed from the glass
sheet. The thicknesses of the ﬁlms were measured with a digital
micrometer.
Nanoporous titania ﬁlms were prepared from a TiO2 sol (HT/SP from
Solaronix). The colloidal thin ﬁlms, [1.75; 2.5; 3.25] μm,were distributed
in a screen-printing device previously acquired with required thick-
nesses. The larger ﬁlms [5; 7.5] μm were applied using the squeegee
print method. The colloid was distributed with a glass rod sliding over
a rim circlemadewith ScotchMagic adhesive tape (3M). After air drying,
the ﬁlms were sintered in an oven at 500 °C for about 90 min. MnIII
5,10,15,20-tetrakis(4-sulphonylphenyl)porphyrinate acetate (Mn-TPPS)
was adsorbed to the surface of nanostructured titania by immersing glass
slides coated with TiO2 in an ethanol solution of the dye for the period of
time required to attain the desired absorptivity. The absorbances at
471.5 nmwerematched at 0.5. Thesemethods produce a uniform titania
layer with a homogenous monolayer of dye adsorbed onto it [42].The thermoelastic expansion that gives rise to PA waves is, in prin-
ciple, non-destructive. In practice, signs of material fatigue are appar-
ent after ca. 30,000 laser shots. This is visually characterized by a
change in color and a decrease in opacity of the ﬁlms. The ﬁlms
used in the experiments described below were regularly replaced.
3.2. Topical formulations
The permeability of the skin of minipigs was tested with a
bacteriochlorin (molecular weight 1.1 kDa) of interest as a photosen-
sitizer in the photodynamic therapy (PDT) of cancer [43,44], and with
Green Fluorescent Protein. The bacteriochlorin was a gift from Luzitin
SA (Portugal), and Green Fluorescence Protein (GFP) was obtained
fromMerck Millipore. The bacteriochlorin and GFP were incorporated
in topical formulations, as described below, and applied to the skin of
minipigs. Bacteriochlorins are particularly suitable for these assays
because, in addition to the molecular weight of 1.1 kDa, they are
stable and have a very characteristic ﬂuorescence with a peak near
750 nm. GFP has a molecular weight of 28 kDa and is also very
convenient to illustrate the increased permeability of skin with the
application of PA waves because its characteristic ﬂuorescence at
510–550 nm is simple to follow.
The bacteriochlorin uptake into the skinwas tested using a Carbopol
type gel with high water percentage. The gel preparation was done in
three steps. First, the solvents of the gel basewere introduced in the fol-
lowing order and stirred magnetically at 2400 rpm: 6% of glycerin,
1.35% of triethanolamine, 1% of carbopol 940, 15% of ethanol absolute
and 76.65% of distilled water. Next, the bacteriochlorin was dissolved
in the solvent mixture ethanol:propylene glycol:oleic acid (16.6:36:2,
% w/w), subject to 1 min of ultrasound to assure complete solubiliza-
tion, and added to the gel base in order to make 44.9% of the formula-
tion. The ﬁnal concentration of the bacteriochlorin in this gel was
0.5%. A formulation with 5% of bacteriochlorin, compensated with the
reduction in gel base, was also tested and did not give signiﬁcantly dif-
ferent results. A formulation with Azone (4%) in lieu of oleic acid, and
compensated by a reduction of ethanol, was prepared with 1% of
bacteriochlorin and tested under similar conditions. To avoid degrada-
tion and maximize polymer swelling, the gels were prepared 24 h
before the experiment and kept at +4 °C.
GFP was dissolved in the amount of water employed to make the
gel base and then the other components of the gel base were added,
together with Azone (4%). The ﬁnal concentration of the GPF in the
gel base was 0.1%, and this was the topical GFP formulation employed
in this work.
The rational to include a permeation enhancer in the topical for-
mulation was to improve the passive delivery of the bacteriochlorin
and GFP. This allows us to compare the best passive delivery with
the dermal delivery with PA waves. The detailed studies on the opti-
mization of the formulation for passive delivery will be published
elsewhere because they are not relevant for the comparison between
active and passive delivery. The Supplementary Data also presents
results obtained with Azone in the place of oleic acid and also with
the porphyrin precursor of the bacteriochlorin mentioned above.
3.3. Generation of photoacoustic (PA) waves
The experiments with excitation at 484 nm and 471.5 nm
employed an EKSPLA OPO model PG-122 pumped by an EKSPLA
NL301G Nd:YAG laser delivering 4–6 ns pulses. Exploratory work
with minipigs and the delivery of GFP employed a Spectra Physics
Quanta Ray 130 Nd:YAG laser to generate PA waves. The delivery of
the bacteriochlorin and the work with volunteers used a portable
Quantel Big Sky Ultra 50 Nd:YAG including a second harmonic gener-
ator (532 nm wavelength output, 8 ns pulse duration) to generate
the PA waves. In particular, the TEWL experiments employed a
Quantel laser with pulse energy densities of 50 mJ/cm2. The laser
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light-to-pressure transducer. This material was conﬁned between an
optical window and a mirror using silicone as acoustic coupler. The
mirror reﬂected the light back into the piezophotonic material and
protected the skin from the laser light. The photoacoustic waves
were transmitted to the skin by physical contact between the back
of the mirror and the skin and the acoustic coupling was improved
placing a thin layer of silicone between the back of the mirror and
the skin of the volunteers, or a thin layer of the topical formulation
between the back of the mirror and the minipig skin.
Pressure wave measurements were made with a calibrated needle
hydrophonemodelMH28 fromForce Technologies orwith Panametrics
(Olympus) contact piezoelectric transducers (100 MHz and 225 MHz),
connected to a DPO7254 Tektronix digital oscilloscope.
3.4. Transdermal delivery in minipigs
In vivo tests employed minipigs obtained from IMIDRA (Instituto
Madrileño de Investigación y Desarrollo Rural, Agrario y Alimentario) -
Aranjuez (Madrid). They were aged 6–8 months, white with brown
spots, and with weights ca. 60 kg. They were received at INRB, Vale de
Santarém (Portugal), where they were accommodated in individual
boxes with 1.5 m2, feed with a standard diet for pigs and water ad
libidum, for an acclimation period of three weeks. The study was
performed in accordance to the Portuguese ethical guidelines on a li-
cense granted by Direcção de Serviços de Saúde e Protecção Animal, ref.
0420/000/000/2007, with the assistance of veterinary surgeons. Access
to food was suspended 24 h before treatment. The backs of the animals
were shaved 24 h prior to the in vivo application of the dermatological
formulations. The formulations, laser system and piezophotonic mate-
rials employed in these experiments were described above. All proce-
dures were carried out under anesthesia. The pre-medication given
30 min in advance was: Azaperone (Stresnil® – Veterinaria ESTEVE –
Spain), 2 mg/kg intramuscular injection+atropine sulfate, 50 mg SC.
The induction was done with ketamine (Clorketam® – Vétoquinol,
France), 20 mg/kg, intramuscular injection. The anesthesia was
maintained with endotracheal intubation, using spontaneous ventila-
tion with 2–3 L/min of oxygen+3% isoﬂurane (Isoﬂo® – Veterinária
ESTEVE, Spain). The skin biopsies were collected under the anesthesia
described above. After the collection of the biopsies, the animals were
killed with an overdose of sodium thiopental (25 mg/kg)+20 ml of
7.5% potassium chloride.
In vivo transdermal delivery and skin biopsies were made with the
following procedure in a temperature-controlled room in the pres-
ence of the investigators and two veterinary surgeons: a) The back
of the minipig was cleaned with ethanol soaked in medical cotton and
allowed to dry. b) Square areas with 1 cm size was delimitated on the
back of theminipig using adhesive tape, resulting in 15 different squares
in each animal. c) The contact times were planned (i.e., 15 min, 30 min,
1 h, 2 h, 3 h) andmarked on the adhesive tape. d) Startingwith the lon-
gest contact time, the formulation containing bacteriochlorin or GFP, de-
scribed above, was applied in the designated areawith a spatula, leaving
a uniform 1 mm layer of the formulation. e) The device to generate PA
waves, described above, was gently pressed against the formulation
and the laser was ﬁred. f) The device was removed and more formula-
tion was added to reform the 1 mm layer of formulation. g) The formu-
lation was occluded with Tegaderm® and aluminum foil for the
desired amount of time. h) After the time difference between the
longest and second-to-longest contact times elapsed, the skin area
assigned to the second longest contact time was treated same way.
i) The appropriate timings were followed in the application of the for-
mulation to each one of the skin areas in such a way that all the contact
times terminated for all the skin areas at the same time. j) At the simul-
taneous end of all the planned contact times, Tegaderm® and alumi-
num were rapidly removed from all skin areas and the formulation
was thoroughly cleaned with absorbing paper and then with ethanolsoaked in medical cotton. k) Two skin biopsies were then rapidly col-
lected from each area. l) Immediately after excision the biopsies were
frozen until further use. m) The minipig was sacriﬁced as described
above. One set of the biopsy punches was used for extraction and quan-
tiﬁcation of the amount of the bacteriochlorin in the skin, whereas the
other set was analyzed using ﬂuorescence microscopy for the depth of
penetration. Passive delivery studies followed the same procedure,
with the same formulations, except that the PAwaveswere not applied.
3.5. Analytical methods
The extraction and quantiﬁcation of the bacteriochlorin in one of
the sets of biopsies were performed according to the following
steps: a) The skin biopsy was sectioned in the smallest pieces possible
with a scalpel. b) These pieceswere transferred to a cup glasswith 2 ml
of dichloromethane and crushed with a shredder, YSTRAL Micro Shaft
6G. c) 8 ml of dichloromethane were added to the resulting mass and
allowed to stand for 6 h. d) A volume of 3 ml of the supernatant was
transferred to a quartz cuvette and its ﬂuorescence intensity was
recorded. The amount of the bacteriochlorin present in each skin biopsy
was determined using a calibration curvemadewith solutions having a
known concentration of the bacteriochlorin in dichloromethane. The
steady-state ﬂuorescence of the bacteriochlorin was measured with a
Horiba-Jovin-Yvon Spex Fluorog 3-2.2 spectrophotometer in a 1 cm
quartz cuvette and corrected for detector wavelength dependence.
The measurement of the depth of penetration of the bacteriochlorin
or GFP in the other sets of biopsies followed the steps: a) Tissue ﬁxation
was made immersing the tissue in paraformaldehyde (4% in aqueous
solution) for at least 24 h, and then in a 25% sucrose solution for at
least 48 h; alternatively, some samples were directly frozen in dry ice.
b) The tissue was frozen in dry ice and then mounted on a holder
with Tissue-Tek O.C.T. Compound (Sakura Finetek Europe B.V.,
Zoeterwoude, Netherlands). c) The tissue was cut in slices with
controlled thicknesses selected between 25 and 100 μm in a cryostat.
d) The skin slices were collected in microscope slides and kept refriger-
ated for microscopy. Fluorescence microscopy was measured with an
Olympus BX51M ﬂuorescencemicroscope equippedwith a UVmercury
lamp (100 WUshioOlympus), using a resolution of 1/4.5 and ampliﬁca-
tion of 10×. The 515 nm excitation cube and the 600–800 nm emission
cube were used for the bacteriochlorin. The 470–495 nm excitation
cube and the 510–550 nm emission were employed to obtain the GFP
ﬂuorescence. The images were processed in a personal computer by
an Olympus Digital DP70 video camera, and analyzed with Olympus
DP Controller 2.1.1.176 and DP Manager 2.1.1.158 software. Confocal
ﬂuorescence of the bacteriochlorin was performed with a LSM 510
Meta (Carl Zeiss, Jena, Germany) confocal microscope, with a ×63 oil
immersion objective (Plan-Apochromat, 1.4 NA; Carl Zeiss), using
λex=514 nm, λem≥650 nm, laser power at 5% and an ampliﬁcation
40×. Confocal ﬂuorescence of GFP in skin slices from experiments
with post mortem minipig skin was visualized under a Leica TCS Sp5
confocal microscope using 488 nm excitation and 510–550 nm emis-
sion light. Themicroscopy is inverted (DMI6000)with awater apochro-
matic objective of 63′ and numeric aperture of 1.2. Before connecting
the confocal mode, the samples are observed with a sodium lamp, as
the radiation source, and with Rhod-DOPE as a ﬂuorescent ﬁlter. The
3D projections were obtained using the analysis software of Leica®.
The sample was excited with the 495 nm line of laser and emission
recovered at 510 nmwith a pinhole of 111.44 μm, using a detector volt-
age of 1150 V and a zoom of 1 or 3. All observations were done at 22 °C.
3.6. Transepidermal water loss (TEWL)
Healthy volunteers gave their informed consent to participate in
the measurement of TEWL in both of their forearms, before and
after the application of PA waves. They were informed that the appli-
cation of the laser-generated PA waves was to take 2 min, and that
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a history of atopic dermatitis, asthma, contact dermatitis or allergy
were excluded from the study. Each subject was tested in both fore-
arms with the same procedure, except that in the ﬁrst procedure
the laser shutter was kept closed (laser OFF). The subjects were not
informed that the ﬁrst exposure was a control experiment. It was
planned to exclude from the study the volunteers reporting discom-
fort in this ﬁrst exposure (laser OFF), but this case was not observed
and all the participants enrolled in the experiment completed it.
The TEWL measurements were made with the following procedure
in a temperature-controlled room in the presence of one volunteer
and, occasionally a second one for acclimatization, and two investiga-
tors: a) A circular area with 1 cm diameter was marked in each fore-
arm and cleaned with medical cotton. b) The erythema in this area
was measured. c) One investigator measured the TEWL in this area
for at least 1 min after stabilization of the measurements. d) A thin
layer of silicone was spread over the selected area. e) The investigator
pressed gently the device generating the ultrasound waves against
the selected area for 2 min – the volunteer did not know of the exis-
tence of a laser shutter. f) The selected area was cleaned with medical
cotton in ca. 15 s. g) One investigator measured the TEWL in this area
for at least 1 min after stabilization of the measurements. h) The
erythema in this area was measured again.
Transepidermal water loss (TEWL) was measured using a
Courage+Khazaka open chamber probe model Tewameter® TM
300, and expressed in g/(cm2 hr). Erythema was measured using a
Courage+Khazaka probe model Mexameter® MX 18, and is
expressed in arbitrary units.4. Results and discussion
4.1. Properties of photoacoustic waves
Table 1 shows the properties of piezophotonic materials made
with photoacoustic calorimetry references dispersed in polystyrene
or adsorbed to TiO2 nanoparticles. Film A immersed inwater was irradi-
ated with 40 mJ/cm2 laser ﬂuence using 8 ns pulse (IL=5 MW/cm2) at
532 nm and the PA wave produced gave pmax=12 bar, as measured
with a 20 MHzneedle hydrophone. This is 8%of the theoretical pressure
predicted by Eq. (1) and corresponds to ηPA=10−5. To the best of our
knowledge, this is the highest ηPA ever reported. The conversion efﬁ-
ciency could be easily improved increasing the laser power density,
but the purpose of this work was to generate PA waves capable of in-
creasing the permeability of the skin with safe laser and ultrasound
powers. Thus, we did not attempt to improve ηPA and produce higher
maximum pressures. On the other hand, the power spectrum of the
PA waves is relevant for the skin permeability and was investigated in
detail.Table 1
Properties of representative piezophotonic materials and laser ﬂuences used in this
work.
Film Material Dye Thickness
μm
λex
nm
A μa
cm−1
Laser
ﬂuence
mJ/cm2
A Polystyrene Mn-TPP 95 532 1.15 120 40 or 50
B Polystyrene Mn-TUP 38 484 1.4 370 50
532 1.1 290
C1–C5 TiO2 Mn-TPPS 1.75–7.5 471.5 0.5 2860–670 32
D Polystyrene Mn-TPP 100 532 1.5 150 50
E Polystyrene Mn-TPP 60 532 1.4 230 50
F Polystyrene Mn-TUP 50 355 3.2 640 10
G Polystyrene Mn-TUP 30 355 >1 >330 50The PA wave of Film A and its fast Fourier transform (FFT) are
shown in Fig. 2A and B. The distribution of frequencies apparently
peaks at 3.5 MHz but this frequency distribution is limited by the
hydrophone response in the high frequency range. Excitation of
Film B using laser pulses at 484 nmwith 6 ns durations and detection
with a 225 MHz transducer gave the PA wave of Fig. 2C and the distri-
bution of frequencies of Fig. 2B. This ﬁlm should produce PA waves
with the duration of the 6 ns laser pulse, which should extend the
useful bandwidth of the ultrasound generated to ca. 200 MHz
[27,45]. Indeed, signiﬁcant frequency components up to 200 MHz
are present in the signal generated by Film B. The response of this
transducer is within −6 dB (i.e., power reduction by a factor of 4)
of its maximum in the frequency range between 98.6 and 335 MHz,
which means that the decrease in the signal by −30 dB (power
reduction by a factor of 1000) from 100 MHz to 250 MHz is unbiased
by the transducer. Ultra-high frequencies are strongly attenuated in
the materials where they propagate and the detected intensities are
diminished even when the source is very close to the detector [46].
We placed Film B directly against the surface of the transducer to
avoid differential attenuation of the ultrasonic frequencies and the
observed maximum slightly below 100 MHz is the true maximum
of the power spectrum. Fig. 2B also shows the frequencies obtained
with the irradiation of a 634 μm thick commercial black polystyrene
disk. The power at 50 MHz is only 1/10 of the peak power at
2.5 MHz generated by this commercial polystyrene and shows that
this material does not meet the limits of photoacoustic spectral
conﬁnement. Fig. 4D shows that in the series of Films C1–C5 with a
constant absorbance A and various thicknesses h, peak pressures
increase as the thickness of the material decreases, as expected
from Eq. (4).
The minimum pressure amplitude that satisﬁes the cavitation
threshold increases with the ultrasonic frequency fUS [47,48]. In
view of the deleterious effect of cavitation, the Mechanical Index of
ultrasound, deﬁned as MI=pmax/√(fUS), where pmax is expressed in
MPa (1 MPa=10 bar) and the ultrasonic center frequency fUS is
expressed in MHz [49], should be lower than 0.5 [50]. Thus, PA
waves with pmax≤50 bar are safe if fUS>100 MHz, just like ultra-
sound waves with pmax≤10 bar if fUS>4 MHz. A 2 min exposure
time to 20 Hz 8 ns pulses of 40 mJ/cm2, gives a temporal average of
the total exposure to ultrasound below 1 W/cm2, which is less than
the exposure level of physiotherapy. Thus, these safe but moderately
intense PA waves have rise times of tens of bar/ns and acoustical
wavelengths (λac=2csτL) of tens of microns. They generate steep
pressure gradients that may transiently perturb the skin and facilitate
transdermal drug delivery.
The data in Fig. 2 provides the grounds to explain in detail the skin
permeabilization mechanism depicted in Fig. 1. The pulse duration
τL=6 ns together with the sound velocity in soft tissues cs =
1540 m/s give an acoustic wavelength λac=18 μm, which is approx-
imately the SC thickness. At the laser ﬂuence rates employed in our
experiments, the PA waves generate a pressure gradient ca. 20 bar
over a distance λac/2, i.e., they can lead to pressure gradients of
2.2 bar/μm. The pressure gradient of therapeutic ultrasound with a
peak pressure of 10 bar and a frequency of 1 MHz, which corresponds
to λac=1500 μm, is 100 times lower.
Mitragotri and co-workers emphasized the difference in scales
between the wavelength of conventional ultrasound and the SC thick-
ness to conclude that mechanical effects do not play an important role
in the permeabilization of the skin with ultrasound in the therapeutic
frequency range [51]. Nevertheless, these authors also recognized
that “mechanical effects could become increasingly important in the
high-frequency range (frequency>3 MHz)” [51]. Ultrasound with
frequencies above 100 MHz produces mechanical stress commensu-
rate with the size of cells. Pressure gradients of 2.2 bar/μm may dis-
place the corneocytes from their native packing positions and open
transient channels for the diffusion of drugs.
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of ultrasound in the transdermal delivery of drugs is cavitation. The
steady pulsation (stable cavitation) or rapid collapse (inertial cavita-
tion) of sub-micron gas bubbles in an ultrasound ﬁeld can induce
disorder in the SC lipid bilayers, thereby enhancing transdermal
transport [51,52]. However, cavitation can be excluded as a possible
mechanism associated with our PA waves on the following grounds:
(i) Stable cavitation is not possible in our experiments because we
employ single and unfocused planar acoustic waves.We produce
one PA wave with one laser pulse, and the maximum frequency
of the laser pulses is 20 Hz. Thus, any bubbles eventually gener-
ated by the ﬁrst PA wave have enough time to dissipate most of
their energy before the second PA wave arrives.
(ii) Low-frequency sonophoresis, for which the role of cavitation is
well established, employs pressure amplitudes of 2 bar and cen-
ter frequencies below 0.1 MHz [53], which give MI>0.6. On the
other hand, our PA waves are characterized by fUS=100 MHz,
compressive pressure amplitudes of 10 bar and tensile stresses
of 5 bar, i. e. MI=0.05. This is well below the cavitation thresh-
old.
(iii) High frequency sonophoresis (center frequencies between 1 and
5 MHz) is known to requiremuch higher pressures to exceed the
cavitation threshold. The measured cavitation pressure ampli-
tude thresholdwas found to depend almost linearly on frequency
with a slope of about 53 bar/MHz and with a 6 bar extrapolated
static pressure threshold [54]. Mitragotri provided evidence for
cavitation inside the SC using ultrasound at 2 W/cm2 and fUS=
1 MHz using long exposure times [51], but in this case the nucle-
ation of small gaseous cavities in a negative pressure cycle of ul-
trasound is followed by the growth of the bubbles throughout
subsequent cycles until the bubbles explode. The PA waves of
our work havemuch higher center frequency and are not applied
in resonance conditions: each PA wave is as independent event,
separated by at least 50 ms from the next event.
(iv) The shock waves produced by the high-energy lasers described
by Doukas [55], or by lithotripsy [56], have peak pressures be-
tween 100 and 1000 bar presented in spikes with microsecond
duration. In the most favorable case, the frequency components
of such waves follow the duration of the spike, which leads to
fUS=1 MHz and MI>10. Such shock waves are most likely to
produce cavitation but have the opposite properties with respect
to our PA waves, which reduce the peak pressure and increase
the center frequency.
4.2. Transepidermal water loss
Following the detailed characterization of the PA waves discussed
above, we performed safety testing in minipigs and then evaluated
how the PA could change the transepidermal water loss (TEWL) of
human skin. Twenty-one healthy volunteers (18–25 years of age)
from a population of medicinal chemistry students at the University of
Coimbra gave their informed consent to participate in blind TEWLmea-
surements before and after the application of PA waves in their ventral
forearms for 2 min. One measurement was made in one forearm of the
volunteer with the laser OFF and another one in the other forearm theFig. 2. Properties of photoacoustic waves. a, Pressure wave produced by Film A upon ab-
sorption of a 40 mJ/cm2 laser pulse at 532 nm, as measured by a 20 MHz needle hydro-
phone. b, FFT of the PA waves shown in panels a and c. c, Pressure wave produced by
Film B upon pulsed laser excitation at 484 nm of either a 634 μm thick commercial
black polystyrene disk (blue line) or of ﬁlm B (red line), as measured by a 225 MHz con-
tact transducer. d, Dependence of the photoacoustic signal intensity on the thickness of
the series of ﬁlms C1–C5 with matched absorbances at the pulsed laser excitation wave-
length of 471.5 nm, as measured by a 100 MHz contact transducer.
Fig. 4. Box plot of pain reported according to a visual analog scale. No pain=0, worst
pain ever=10. Each box encloses 50% of the data, and outliers as displayed as individ-
ual points. The arrow indicates the same subject that appears as an outlier in the
control (laser OFF) and in the experiments with laser ON.
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laser ﬂuence per pulse was set to 50 mJ/cm2 (6.25 MW/cm2).
The TEWLmeasured on the left and right volar forearms of 12 females
and 9 male volunteers aged 18–25 years before the application of PA
waves was 14.3±0.6 g cm−2 h−1 (average±s.e.m.), in good agree-
ment with the values reported in the literature for the use of the open
chamber Tewameter [13]. The average (±s.e.m.) TEWL increase due to
simple occlusion with the laser OFF was 5.4±0.9 g/(cm2 h), while the
2 min exposure to PA waves increased the TEWL by 17±3 g/(cm2 h).
Thus, there is a statistically signiﬁcant difference (t probability b0.005)
between the increase in TEWL due to simple occlusion or to 2 min of
PAwaves. Fig. 3 presents the TEWL changes and their exponential return
to normal values with a half-life of τ1/2=40 s. Considering that the ﬁrst
TEWL measurement was made 15 s after lifting the material from the
skin, to allow for the cleaning of the silicone with absorbing paper, and
assuming the same exponential relaxation in the ﬁrst 15 s, we obtain
an initial TEWL increase of 21.5 g/(cm2 h), and 5.9 g/(cm2 h) of which
are due to the occlusion. This transient increase by 5.9 g/(cm2 h)
comes from near-surface water trapped by occlusion. The remaining in-
crease, 16 g/(cm2 h), is due to the increased permeability of the skin
when subjected to 2 min of PA waves.
Erythema was measured at the site of PA waves exposure before
and after the measurement of TEWL, and a signiﬁcant increase was
observed, from 254±8 to 324±15 (t probability b0.0001). This in-
crease is barely perceptive to the view and is resolved in a few mi-
nutes. A visual analog scale was employed for rating pain, from 0
(no pain) to 10 (worst pain ever). This scale was employed to score
the pain after 2 min of the control (laser OFF) experiments and
after 1 min and 2 min of the laser ON experiment. Scores of 0 to 2
were reported with the laser OFF and with 18 volunteers with the
laser ON. Two volunteers reported a score of 3 and one a score of 5.
The TEWL of this volunteer increased by 40 g/(cm2 h) and was the
second highest registered. The box plot of Fig. 4 clearly shows the vol-
unteer with a score of 5 is also an outlier in the control experiment.
Thus, TEWL in healthy volunteers increases by more than factor of 2Fig. 3. Changes in transepidermal water loss (average±s.e.m.) of the right (in red) and
left (in blue) ventral forearms of volunteers. The right ventral forearms were exposed
for 2 min to PA waves generated by Film A or B while subject to 50 mJ/cm2 laser pulses
at 20 Hz, and the change is the TEWL after the exposure to the PA waves minus the ini-
tial TEWL. The TEWL of the left ventral forearms was measured with the same protocol
but with the laser off. The silicone used to improve the acoustic coupling was cleaned
before the ﬁrst TEWLmeasurement reported in each experiment, and this took ca. 15 s.after 2 min of exposure to PA waves at 20 Hz, and then the skin re-
covers its protective function in 2 min, leaving no signs of damage
to the skin and causing mostly a gentle warming sensation.
A similar increase by a factor of two in TEWL was reported for 10×
sequential tape strippings with D-Squame® tapes [14], and in other
similar studies [57], but the increased TEWL remains at the high level
for at least two hours after the tape stripping. The effect on TEWL of
metal microneedle arrays with needles lengths of 200–400 μm and di-
ameters of 200–300 μm was also recently reported [57]. The increases
in TEWL with such microneedles did not reach a factor of two and the
largest increases were associated with longer skin recovery times,
typically more than two hours [57]. Iontophoresis applied for 3 h at a
current density of 250 μA/cm2, which corresponds to a total delivery
current higher than usual for this transdermal delivery technique,
showed that the effect of iontophoresis on TEWL is not as pronounced
as the effect of simple occlusion [58]. Additionally erythema was ob-
served in all subjects of that study and edema was also occasionally
observed.
The rapid increase in TEWL with the application of PA waves
followed by an exponential relaxation to baseline values in 2 min
seems to be a distinct feature of the broadband PA waves with steep
pressure gradients generated in these experiments. It is likely that
the gentle warming experienced by some of the volunteers contrib-
utes to the increase in TEWL. In fact, Maibach and co-workers [59]
quantiﬁed the skin temperature dependence of TEWL and using
their equations we calculate that a temperature increase from 34 °C
to 38 °C may increase the TEWL from 14 to 18 g/(cm2 h). Ogura
and co-workers took advantage of this effect by combining the
laser-induced stress waves with skin heating [60], while trying to
avoid the use of high peak pressures that are associated with the
risk of mechanical damage to the skin. These authors showed that
the skin permeability of a photosensitizer used in PDT (Photofrin,
which is a mixture of hematoporphyrin derivatives with molecular
weights between 1.2 and 4.9 kDa) is enhanced by pressures waves
with 520 bar peak pressures and 1 μs pulse widths, generated by
laser ablation of black rubber, when the surface temperature of the
skin is heated to 48 °C. In our experiments we observed a TEWL
increase from 14 to 30 g/(cm2 h), which means that the expected
temperature change (+4 °C, +4 g/(cm2 h)) is a minor contributor
to the observed increase. On the other hand, the PA waves generated
in the limits of photoacoustic spectral conﬁnement have the duration
of the laser pulse and the rate of pressure increase of a 12 bar PA
Fig. 5. Representative microscopy images of minipig skin biopsies after in vivo trans-
dermal delivery of a bacteriochlorin. a, Confocal microcopy of a 1.1 kDa bacteriochlorin
after 2 h of passive diffusion (λex=514 nm, λem≥650 nm, laser power at 5%, ampliﬁ-
cation 40×). b, Confocal microscopy of the same bacteriochlorin (under the same con-
ditions) 30 min after the photoacoustic delivery with Film E and 50 mJ/cm2 laser
pulses at 20 Hz for 25 s.
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piezophotonic material is >2 bar/ns. This is remarkably similar to
the magnitude of the pressure rise times between 2.5 and 50 bar/ns
of the pressure transients reported by Doukas and co-workers [25].
Pressure rise times are related to pressure gradients by the speed of
sound and, in tissues, the values above correspond to pressure
gradients>1 bar/μm. Although these methods are based on different
approaches to generate pressure transients, they cause similar pres-
sure gradients and should produce the same effects (i.e., the expan-
sion of lacunar domains), which are manifested macroscopically as
an increase in the permeabilization of the SC. In summary, the expo-
sure to safe PA waves rapidly increases in the TEWL of healthy volun-
teers from 14 g/(cm2 h) to 36 g/(cm2 h), but the SC recovers its
protective function two minutes after the end of such PA waves.
4.3. Drug delivery
The large change in TEWL observed with the application of PA
waves generated by piezophotonic materials and the correlation be-
tween TEWL and the skin barrier function [14,16–19], suggest that
such PA waves can be used to increase the permeability of skin to
drugs. The control of skin permeability without causing discomfort
or lasting effects is especially interesting for the case of large mole-
cules (>500 Da) and proteins, which have small or negligible ﬂows
through the SC. We selected a bacteriochlorin with a molecular
weight of 1.1 kDa and GFP (28 kDa) to test the dermal delivery
with PA waves because these species cover a range in sizes and struc-
tures that is of clinical interest, and also because their ﬂuorescence
simpliﬁes the analytical procedures. In vivo experiments with
minipigs were run 3 years apart, where the ﬁrst set of experiments
investigated mostly safety and the second set were conﬁrmatory ex-
periments with optimized piezophotonic materials. Minipig skin
samples collected after the ﬁrst set of experiments were kept
refrigerated and used for various optimization experiments in be-
tween in vivo experiments. We focus below the in vivo studies of
drug ﬂow through minipig skin because they are the most adequate
to anticipate protocols for eventual clinical studies. Other micro-
graphs illustrating of increased diffusion elicited by PA waves in vivo
and post mortem are presented as Supplementary Data.
Fig. 5 presents representative confocal microscopy images of in
vivo experiments with minipigs using a topical formulation of the
bacteriochlorin. In the passive delivery experiment, the formulation
was placed in contact with the skin and occluded for 2 h before the
animal was sacriﬁced. In the active delivery experiment, the same for-
mulation was placed 20 min before the sacriﬁce of the animal, subject
to PA waves generated with ﬁlm E for 25 s with a 20 Hz repetition
rate, and occluded. Skin biopsies were collected just before the
death of the animal. After the treatment of the skin biopsies, confocal
microscopy revealed that the depth of diffusion increased from 15 μm
for passive diffusion in 2 h (Fig. 5A) to 35 μm in 30 min with the ap-
plication of PA waves (Fig. 5B). This is consistent with the role of
stress waves with steep pressure gradients in disturbing temporarily
the SC [24], with the measurements of TEWL and with the ability of
the molecules to diffuse more easily in the epidermis. It must be em-
phasized that the TEWL measurements in volunteers did not employ
any permeation enhancer, whereas the formulations used for passive
and active delivery included oleic acid or Azone in their compositions.
Penetration enhancers are known to extend the transient increase of
skin permeability induced of stress waves [61].
Confocal microscopy is appropriate to assess the depth of perme-
ation of ﬂuorescent drugs, but the quantiﬁcation of the ﬂow of a drug
through a given surface area of skin requires other analytical tech-
niques. The ﬂow was investigated extracting the bacteriochlorin from
minipig skin biopsies collected after different contact times of the topi-
cal formulation with the skin. The amount of bacteriochlorin extracted
was then quantiﬁed by ﬂuorescence using a calibration curve. Thecalibration curve in the Supplementary Data illustrates the sensitivity
and accuracy of this technique in the nanomolar concentration range.
The distinctive ﬂuorescence of tetraphenylbacteriochlorins near
750 nm avoids contaminations with endogenous ﬂuorophores [62].
Passive delivery employed contact times of the formulation with the
minipig skin, under occlusion, of 30 min, 1 h, 2 h and 3 h. The contact
times for active delivery with oleic acid as permeation enhancer were
15 min, 30 min and 1 h. In all the experiments, the contact times
were programmed to ﬁnish at the same time, and at that time the
minipigs were sacriﬁced.
The mass of bacteriochlorin extracted in the passive delivery
experiments with oleic acid increases with time, from 0.031±
0.006 μg at 30 min to 0.089±0.016 μg at 3 h. When PA waves were
applied, the average mass extracted between 15 and 60 min of con-
tact of the same formulation with the skin was 0.082±0.016 μg. An
alternative formulation using Azone as permeation enhancer was
also tested. The average mass extracted after 1 h of passive delivery
with this formulation was 0.025±0.009 μg and remained at this
level after 3 h, whereas with the application of the PA waves the
average mass extracted between 5 and 16 min of skin contact was
0.086±0.020 μg. The passive permeation with oleic acid is better
than with Azone, but the active permeation is not very sensitive to
the permeation enhancer. The detailed statistics are presented in
the Supplementary Data.
Fig. 6 compares the ﬂuxes obtainedwith PAwaves andwith passive
delivery, both employing oleic acid as permeation enhancer. It is clear
the effect of the PA waves generated with Film E and 8 ns laser pulses
(ﬂuences of 25 or 50 mJ/cm2) at 20 Hz for 25 s was most pronounced
in the ﬁrst 15 min after the application of the PA waves and that this
translated in an active ﬂow of 2.6±0.6 μg/(cm2 h). After 30 min the
ﬂux measured for the active permeation, 1.3±0.2 μg/(cm2 h), is still
signiﬁcantly (pb0.05) higher than that of the passive permeation,
0.49±0.09 μg/(cm2 h), but after one hour the difference is no longer
signiﬁcant. This is entirely consistent with the TEWL, and reﬂects the
recovery of the barrier function of the SC after the perturbation with
Fig. 6. Fluxes obtained with PA waves and with passive delivery. The same formulation
with bacteriochlorin and oleic acidwas used in both experiments. The PAwaveswere gen-
erated with Film E and 8 ns laser pulses (ﬂuences of 25 or 50 mJ/cm2) at 20 Hz for 25 s.
Fig. 7. Representative microscopy images of minipig skin biopsies after transdermal de-
livery of GFP. a, Fluorescence microscopy of GFP (excitation ﬁlter 470–495 nm, emis-
sion ﬁlter 510–550 nm) in biopsies collected 20 min after photoacoustic delivery
with Film F and 12 laser pulses at a ﬂuence of 10 mJ/cm2. d, Confocal microscopy of
GFP in biopsies (λex=488 nm, λem≥495 nm, laser power at 50%) collected 20 min
after photoacoustic delivery with Film G and 6 laser pulses at a ﬂuence of 50 mJ/cm2.
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the active ﬂux must converge to the passive ﬂux as the skin fully
recovers. Time averaging of the ﬂuxes attenuates the differences for
longer contact times between the formulation and the skin. The active
ﬂux measured for the formulation with Azone corroborates these ﬁnd-
ings, as it decreases from 5.9±1.5 μg/(cm2 h) in the ﬁrst 10 min to
1.2±0.2 μg/(cm2 h) in the ﬁrst 30 min (see Supplementary Data). In
the case of the formulation with oleic acid, the active ﬂux of the
bacteriochlorin 15 min after the application of PA waves is 5.3 times
higher than the highest passive ﬂux with this formulation.
Following the successful administration of a large molecule with
PA waves, the transdermal delivery of GFP was attempted with the
same gel base formulation. GPF was incorporated to reach 0.1% the
gel base, which contained 4% of Azone. The formulation was placed
in contact with the skin of a minipig for 4 h. However, the passive
dermal delivery of GFP in this topical formulation failed to lead to
measurable GFP ﬂuorescence in skin biopsies. On the other hand,
when the same formulation was placed in contact with the skin of
minipigs and it was subject to 12 PA waves with Film F or 6 PA
waves with Film G, extensive GFP distribution in the epidermis was
found after 20 min of contact of the formulation with the skin, as
shown in Fig. 7. GFP ﬂuorescence and confocal microscopies refer in
vivo and postmortem topical experiments, respectively. The SC
remained intact after all the experiments.
The micrographs of Fig. 7 suggest that GFP diffused by h≈50 μm
in t=20 min. Under these conditions its diffusion coefﬁcient is D=
h2/(2 t)≈10−8 cm2/s, which is one order of magnitude below the
diffusion coefﬁcient of yellow ﬂuorescent protein in cells [63]. The
diffusion coefﬁcient of proteins is related to the molecular weight
M, temperature T and viscosity η of the medium [64]
D ¼ 8:34x10–8 T= ηM1=3
 
ð5Þ
We obtain η≈20 cp at T=37 °C, which is close to the viscosity of
oleic acid at the same temperature. These are physically realistic
values for the diffusion coefﬁcient and medium viscosity.
Seminal work on the permeabilization of skin to large drugs with a
single high pressure wave was published by Doukas and co-workers
[25], which included insulin in their pallet of drugs [65]. These
authors emphasized that the ablation of polystyrene targets by laser
pulses with ﬂuences ca. 5 J/cm2 can generate pressure waves with
amplitudes between 300 and 1000 bar, that are much more effectivein permeabilizing the SC than the pressure waves with amplitudes of
1 to 5 bar usually generated in conventional ultrasound techniques. It
was further observed that the onset of SC permeabilization occurred
at 350 bar [25]. Ogura and co-workers used stress waves with
520 bar peak pressures and 1 μs pulse widths for the same purpose
[60]. Our work shows the increase in the permeability of the SC to
water, to a 1.1 kDa molecule and to a 28 kDa protein with PA waves
having amplitudes ca. 10 bar generated with laser ﬂuences lower than
50 mJ/cm2. These studies have in common the use of pressure gradients
larger than 1 bar/μm. The PA waves generated with piezophotonic ma-
terials attain such large pressure gradients with peak pressures below
20 bar and Mechanical Indices below the cavitation threshold because
of they have signiﬁcant ultrasonic frequencies above 100 MHz.
5. Conclusions
Light-to-pressure transduction was improved using thin materials
with a large Grüneisen coefﬁcients and incorporating in such mate-
rials a dye that gives the following properties to the (piezophotonic)
material: i) μa>100 cm−1 at the incident laser light, ii) ultrafast
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rials absorb short laser pulses (b10 ns) with modest laser ﬂuences
(b50 mJ/cm2), they generate PA waves with moderate peak pres-
sures (b50 bar) but very high rise times (>1 bar/ns) that transiently
permeabilize the stratum corneum to large molecules and proteins.
PA waves with these properties increased the TEWL of human skin
in a painless and reversible manner. Such PA waves also increased
signiﬁcantly the initial ﬂuxes of a 1.1 kDa molecule and a 28 kDa pro-
tein through the stratum corneum of minipigs. The transient impair-
ment of the skin barrier function was observed for a wide range of
skin conditions (defrosted skin to in vivo), molecular sizes and polar-
ities of skin permeants (water to GFP), and laser pulses (single-shot
to 20 Hz, 25 to 50 mJ/cm2).
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